Showing results 10 to 13 of 13
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine | 2013 | 84 | ||
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs | 2014 | 59 | ||
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Journal:Cancer Chemotherapy and Pharmacology | 2015 | |||
2013 | 91 |